Company logo

Learn how optimizing medication therapy improves patient health

Medication management programs have been a standard part of healthcare for over a decade now, and yet they have done little to impact the 16% of healthcare spending wasted on medication-related problems.

Join Terry McInnis, MD, MPH, CPE to learn how AI-enabled medication optimization can help patients achieve their health goals while reducing their cost of care.

Register now to start improving outcomes and decreasing cost of care now.

Your Presenter

Profile
Terry McInnis, MD, MPH, CPE
Advisor and CMO
Arine
Terry is the recognized national expert in effective pharmacy spend and medication management. She currently serves as President of Blue Thorn Inc. and as a consultant Chief Medical Officer for Arine, an AI driven technology company devoted to optimizing medications. A strategist in value-based care, she has successfully positioned organizations throughout the health care continuum to assume risk.
  • Profile
    Terry McInnis, MD, MPH, CPE
    Advisor and CMO
    Arine
    Terry is the recognized national expert in effective pharmacy spend and medication management. She currently serves as President of Blue Thorn Inc. and as a consultant Chief Medical Officer for Arine, an AI driven technology company devoted to optimizing medications. A strategist in value-based care, she has successfully positioned organizations throughout the health care continuum to assume risk.

Here's what you'll learn

276,000 people still die per year as a result of non-optimized medications, making medication-related deaths the fourth leading cause of death in the United States. 750 older adults per day are hospitalized because of medication-related problems

Learn from Dr. McInnis how to prevent these costly and deadly medication-related problems before they happen.
  • The staggering cost of non-optimized medications
  • What's wrong with legacy medication management
  • How to leverage AI to optimize medications


Testimonial profile image
Arine provides capabilities that will help us scale the program to deliver personalized medication therapy to more patients, and accelerate outcomes that we know can be achieved through CMM.
Steve Chen, Founder – California Right Meds Collaborative & Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy at the USC School of Pharmacy